Should We Give Cannabis A Chance? Managing Pain in the Opioid Crisis .
OrthoEvidence Journal (OE Journal) - OE Original
OE Journal. 2019;7(3):1Interest in medical cannabis continues to grow as patients seek alternatives to traditional pain therapies, particularly opioids, which offer modest benefit and carry notable risks. Evidence from dozens of randomized trials suggests cannabinoids can provide small short-term improvements in chronic non-cancer pain, with the greatest effect seen within the first couple of months and a tapering impact by six months. Serious harms do not appear to increase, though non-serious side effects such as dizziness or fatigue are more frequent. The overall picture supports modest short-term pain relief, while long-term effectiveness remains uncertain and a priority for future research.
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!